Summary of the 2021 Patient Education & Advocacy Summit
For the second consecutive year, the Celiac Disease Foundation hosted the Patient Education & Advocacy Summit.
Continue ReadingFor the second consecutive year, the Celiac Disease Foundation hosted the Patient Education & Advocacy Summit.
Continue ReadingThe Celiac Disease Foundation recently published an article in Mediaplanet’s Autoimmune Diseases digital campaign.
Continue ReadingThe Celiac Disease Foundation is proud to have been involved by recruiting patients essential for this trial’s success.
Continue ReadingThe NIH Accelerating Progress in Celiac Disease Workshop is a direct outcome of our advocacy efforts in Washington, DC. CEO Marilyn Geller was invited to speak about what our celiac community needs. Watch her presentation here.
Continue ReadingAnokion SA announced that they have initiated patient dosing in the multiple ascending dose (MAD) portion of its ACeD study.
Continue ReadingThe ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.
Continue ReadingThe Celiac Disease in Learning Environments: A Continuing Education Program for Nurses Who Care for Children with Celiac Disease training seminar will complement the recommendations found in the 2020 Voluntary Recommendations for Managing Celiac Disease in Learning Environments.
Continue ReadingRegistration is open for Virtual Camp Celiac 2021 for children ages 9-17 years old, diagnosed with celiac disease requiring a lifelong strict gluten-free diet.
Continue ReadingThe Celiac Disease Genomic Environmental Microbiome and Metabolomic (CDGEMM) study is revealing how genetic and lifestyle factors make children susceptible to autoimmune diseases such as celiac disease, inflammatory bowel disease, and multiple sclerosis.
Continue ReadingWith your help, we have invested significant resources into changing that reality in Washington, DC, and we are beginning to see a return on that investment.
Continue Reading